Salbutamol

This page shows anti-doping rule violation data we have registered for Salbutamol.

Number of cases in Salbutamol Last 10 Years

Salbutamol

Salbutamol ranks #49 globally among prohibited substances, with 69 registered cases (0.5% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,710 verified cases. Kenya leads with 7 cases, while Track and field is the most affected sport (20 cases).

Cases of Salbutamol by Sport
Track and field
20
Cycling
10
Rugby
7
Soccer
4
Tennis
4
Top Sport: Track and field

20

Track and field cases

0%

Of all violations

69

Total Salbutamol cases
Track and field's share of Salbutamol violations 0%
20 of 69

Track and field has the most recorded cases of Salbutamol violations globally, with 20 registered cases — 0% of all 69 verified cases.

Cases of Salbutamol by Country
Kenya
7
United Kingdom
7
France
7
USA
6
Australia
5
Top Country: Kenya

7

Kenya cases

10.1%

Of all violations

69

Total Salbutamol cases
Kenya's share of Salbutamol violations 10.1%
7 of 69

Kenya leads in Salbutamol violations globally, with 7 registered cases — 10.1% of all 69 verified cases.

Global Substance Ranking

Salbutamol ranks #49 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,364
#2 Methandienone
835
#3 Norandrosterone
781
#4 Testosterone
758
···
#49 Salbutamol
69
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 91.3%
63 cases
Female 8.7%
6 cases
Analysis: has a notably higher proportion of male cases (91.3%) compared to the global average (80.2%), a difference of 11.1 percentage points. Global average: 80.2% male, 19.8% female
Average Suspension Length
18.2
months
Salbutamol
30.1
months
Global average

The average suspension for Salbutamol violations is 18.2 months, shorter than the global average of 30.1 months.

This substance was first listed in the IOC doping list in 1988 as a permitted beta-2 agonist via inhalation. Later listed under both stimulants and anabolic agents depending on dose and route of administration.

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,710 verified anti-doping rule violations across all sports and all countries, and is updated regularly.